| N-of-1 trial of a statin, placebo, or no treatment to assess side effects FA Wood, JP Howard, JA Finegold, AN Nowbar, DM Thompson, ... New England Journal of Medicine 383 (22), 2182-2184, 2020 | 264 | 2020 |
| Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis MA Kelshiker, H Seligman, JP Howard, H Rahman, M Foley, AN Nowbar, ... European heart journal 43 (16), 1582-1593, 2022 | 218 | 2022 |
| Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized … L Chacko, J P. Howard, C Rajkumar, AN Nowbar, C Kane, D Mahdi, ... Circulation: Cardiovascular Quality and Outcomes 13 (2), e006363, 2020 | 162 | 2020 |
| Side effect patterns in a crossover trial of statin, placebo, and no treatment JP Howard, FA Wood, JA Finegold, AN Nowbar, DM Thompson, ... Journal of the American College of Cardiology 78 (12), 1210-1222, 2021 | 155 | 2021 |
| Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices … Y Ahmad, M Götberg, C Cook, JP Howard, I Malik, G Mikhail, A Frame, ... JACC: Cardiovascular Interventions 11 (20), 2019-2031, 2018 | 115 | 2018 |
| A placebo-controlled trial of percutaneous coronary intervention for stable angina CA Rajkumar, MJ Foley, F Ahmed-Jushuf, AN Nowbar, FA Simader, ... New England Journal of Medicine 389 (25), 2319-2330, 2023 | 109 | 2023 |
| Diagnosis and management of iatrogenic cardiac perforation caused by pacemaker and defibrillator leads CA Rajkumar, S Claridge, T Jackson, J Behar, J Johnson, M Sohal, ... EP Europace 19 (6), 1031-1037, 2017 | 78 | 2017 |
| Dobutamine stress echocardiography ischemia as a predictor of the placebo-controlled efficacy of percutaneous coronary intervention in stable coronary artery disease: the … RK Al-Lamee, MJ Shun-Shin, JP Howard, AN Nowbar, C Rajkumar, ... Circulation 140 (24), 1971-1980, 2019 | 69 | 2019 |
| The effect of age on vascular compliance in man: which are the appropriate measures? CJ Bulpitt, JD Cameron, C Rajkumar, S Armstrong, M Connor, J Joshi, ... Journal of human hypertension 13 (11), 753-758, 1999 | 64 | 1999 |
| Safety of revascularization deferral of left main stenosis based on instantaneous wave-free ratio evaluation T Warisawa, CM Cook, C Rajkumar, JP Howard, H Seligman, Y Ahmad, ... Cardiovascular Interventions 13 (14), 1655-1664, 2020 | 55 | 2020 |
| ‘Faith Healing’and ‘Subtraction Anxiety’in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial CA Rajkumar, SS Nijjer, GD Cole, R Al-Lamee, DP Francis Circulation: Cardiovascular Quality and Outcomes 11 (3), e004665, 2018 | 50 | 2018 |
| Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis Y Ahmad, O Demir, C Rajkumar, JP Howard, M Shun-Shin, C Cook, ... Open Heart 5 (1), e000748, 2018 | 42 | 2018 |
| Determining the predominant lesion in patients with severe aortic stenosis and coronary stenoses: a multicenter study using intracoronary pressure and flow Y Ahmad, J Vendrik, A Eftekhari, JP Howard, C Cook, C Rajkumar, I Malik, ... Circulation: Cardiovascular Interventions 12 (12), e008263, 2019 | 31 | 2019 |
| Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial S Ganesananthan, CA Rajkumar, M Foley, D Thompson, AN Nowbar, ... European heart journal 43 (33), 3132-3145, 2022 | 30 | 2022 |
| Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial MJ Foley, CA Rajkumar, F Ahmed-Jushuf, FA Simader, S Chotai, ... The Lancet 403 (10436), 1543-1553, 2024 | 29 | 2024 |
| Revascularization in stable coronary artery disease RK Al-Lamee, M Foley, CA Rajkumar, DP Francis bmj 377, 2022 | 23 | 2022 |
| Achieving optimal medical therapy: insights from the ORBITA trial M Foley, CA Rajkumar, M Shun‐Shin, S Ganesananthan, H Seligman, ... Journal of the American Heart Association 10 (3), e017381, 2021 | 17 | 2021 |
| Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial V McCreanor, A Nowbar, C Rajkumar, AG Barnett, D Francis, N Graves, ... BMJ open 11 (2), e044054, 2021 | 15 | 2021 |
| Moving the Goalposts Into Unblinded Territory The Larger Lessons of DEFER and FAME 2 and Their Implications for Shifting End Points in ISCHEMIA CA Rajkumar, SS Nijjer, GD Cole, R Al-Lamee, DP Francis CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES 11 (3), 2018 | 15 | 2018 |
| Adenosine induced ventricular fibrillation in a structurally normal heart: a case report CA Rajkumar, N Qureshi, FS Ng, VF Panoulas, PB Lim Journal of Medical Case Reports 11, 1-5, 2017 | 15 | 2017 |
